Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Skin diseases are changing, with more allergic and immune-related conditions, but infections remain a major concern.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.

Older age and existing health issues increase COVID-19 death risk.

Communicable skin diseases are the most common at Bahawal Victoria Hospital, requiring public health action to reduce their impact.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

The document concludes that understanding the types and symptoms of PCOS is key to improving diagnosis and treatment.

Interest in acne is rising, but research funding has significantly decreased.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata causes hair loss and has various treatment options, but responses differ.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Older people at home often have skin issues, but there's little evidence on how to prevent or treat them effectively.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Skin infections and rashes are the most common skin problems in children.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.